California State University - Interdisciplinary Cancer Meeting (CSU-ICM)

R13应用 凯尔伯、塔梅、德·贝拉德 标题：加州州立大学-跨学科癌症会议(CSU-ICM) 项目总结 所有癌症类型的平均死亡率保持在30%以上。发展，发展 肿瘤学研究中中心问题的变革性解决方案，我们已经建立 两年一度的加州州立大学-跨学科癌症会议(CSU-ICM)。 这个应用是为了支持2022年肿瘤微环境会议： 挑战和机遇将于10月21日(星期五)在加利福尼亚州 北岭州立大学广场索尔演奏厅。这次会议讨论了 需要癌症研究会议，为以下方面提供负担得起的重点平台 生命科学家、非生命科学家和癌症专家之间的跨学科交流。 2018年首届CSU-ICM欢迎Joan Brugge博士和150多名与会者。这个 由于COVID19,2020年的第二次CSU-ICM是虚拟的，但取得了巨大成功 欢迎卡洛斯·阿特加博士和70多名与会者。此应用程序基于 从2018年和2020年的活动中收集的初步数据表明 在种族、学科、地域和机构层面上的参与。我们假定 本次会议的战略性扩展将促进新的、协作的调查路线 这导致了癌症研究的变革性进展，并增加了 肿瘤学研究。简短的讲座将由教职员工领导和 围绕学员演示设计-提高学员的向上流动性 传统上在癌症研究中的代表性不足。癌症幸存者的参与- 倡导者将强调，需要确保即使是最基础的科学研究 是基于清晰的个人观点。世界知名的全体演讲者确保 最高质量的科学交流。研究生院信息交流会 为本科生和硕士研究生提供实实在在的渠道 教职员工代表对课程和应用程序细节的有意义的见解 一流的R1机构。最后，海报会议的目的是促进科学 交流、建立联系的机会和对正在进行的工作的建设性反馈。在……里面 总之，CSU-ICM旨在促进科学知识、学习和 发现；促进专业发展；以及准备多样化的科学 同时还满足了更广泛的癌症研究中的重要需求 社区。

R13 Application Kelber, Tamae, De Bellard Title: The California State University – Interdisciplinary Cancer Meeting (CSU-ICM) PROJECT SUMMARY The average mortality across all cancer types remains at over 30%. To develop transformative solutions to central problems in oncology research, we have established the biennial California State University – Interdisciplinary Cancer Meeting (CSU-ICM). This application is to support the 2022 meeting on The Tumor Microenvironment: Challenges and Opportunities that will be held on Friday, October 21 at the California State University Northridge, Plaza del Sol Performance Hall. This meeting addresses the need for cancer research meetings that provide affordable and focused platforms for interdisciplinary exchange between life scientists, non-life scientists and cancer experts. The inaugural 2018 CSU-ICM welcomed Dr. Joan Brugge and over 150 participants. The second CSU-ICM in 2020 was virtual due to COVID19 but was a big success and welcomed Dr. Carlos Arteaga and over 70 participants. This application is based upon preliminary data collected from the 2018 and 2020 events demonstrating diversity of participation at ethnic, discipline, geographic and institute levels. We postulate that strategic expansion of this meeting will stimulate novel, collaborative lines of investigation that lead to transformative advances in cancer research and increase diversity in oncology research. The short talk sessions will be chaired by faculty leaders and designed around trainee presentations - increasing the upward mobility of those traditionally underrepresented in cancer research. Involvement of cancer survivor- advocates will underscore the need to ensure that even the most basic science research is grounded in clear personal perspective. The world-renowned plenary speakers ensure the highest quality of scientific exchange. The graduate school information session will provide a tangible conduit for undergraduate and masters-level graduate students to gain meaningful insights about program and application details from faculty representatives at top-tier R1 institutions. Finally, the poster session is designed to foster scientific exchange, networking opportunities and constructive feedback on work-in-progress. In summary, the CSU-ICM is designed to advance scientific knowledge, learning, and discovery; promotion of professional development; and preparation of a diverse scientific workforce while also fulfilling an important need in the broader cancer research community.